reference/34638383

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34638383

Outgoing Links

Predicate	Object
contentType	Observational Study\|Journal Article\|Research Support, Non-U.S. Gov't\|Research Support, N.I.H., Extramural\|Research Support, U.S. Gov't, Non-P.H.S.
endingPage	180
issn	0022-3565 1521-0103
issueIdentifier	2
pageRange	169-180
publicationName	The Journal of pharmacology and experimental therapeutics
startingPage	169
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_448c3d7a8b95445db230c0de0b6d375a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c81c82b4ad9caa060230b3c9689699b7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cf5b9d5995507abc870f68cd20a978d7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e3c18600b59b2612497bf6b95256a2d6
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bd2bbe1c31bea34ce6f443cdc675ae59 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c65ca3b7cde2f578b0a0610d0c1f60b7 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6fac77ec8b853b8acf9cf537775fff1a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_305fffe9a71f89eceec67b281d3cd0d5 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f509b05c0441e34d4112da2458b9539f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2c91d8aa023f06712ff25b78c179406d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_49920548df96119e59e55b31b21e79f3 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fdc9bd62ee7e9968160f3e3c6450b28d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_cf771db5586ff1a47bdb5b59f17f2e28 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_00b75bb9767ccdf7d91edc9b8ef9d9f7
bibliographicCitation	Wancewicz B, Zhu Y, Fenske RJ, Weeks AM, Wenger K, Pabich S, Daniels M, Punt M, Nall R, Peter DC, Brasier A, Cox ED, Davis DB, Ge Y, Kimple ME. Metformin Monotherapy Alters the Human Plasma Lipidome Independent of Clinical Markers of Glycemic Control and Cardiovascular Disease Risk in a Type 2 Diabetes Clinical Cohort. J Pharmacol Exp Ther. 2023 Aug;386(2):169–80. PMID: 36918276; PMCID: PMC10353072.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c97d2dcd937f5b258fe1bca4dcd8f11c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e37002190b21b20730732ec44e81b892 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0869-9699 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c15243c997ebd7e4d960d58910c4d1f7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_94251d5da749cffaba7d52aae124f37c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b4eb0b1ea5c3b272d34d8df9df8747c6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_366729b5e831c5646b06d1832316647a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f0aefc4f7d27b10e55d5e8a03a30f7aa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d8562c3929d8debde7580645bfe2ac1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f14695bbdbb6c51154a043c50f6c6836 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_59d3ca2ab4e7b4fac65b020798ff0be8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1a18f08d7e2801b30c693d39877e91e8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0ee84a845b9d30f4406f4393e12769e1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ee452c279fdbe68f29d95c197cc97f6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64d304ef8614b340af5bc464be951d07
date	2023-03-14^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC10353072 https://pubmed.ncbi.nlm.nih.gov/36918276 https://doi.org/10.1124/jpet.122.001493
isPartOf	https://portal.issn.org/resource/ISSN/1521-0103 https://portal.issn.org/resource/ISSN/0022-3565 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5173
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Metformin Monotherapy Alters the Human Plasma Lipidome Independent of Clinical Markers of Glycemic Control and Cardiovascular Disease Risk in a Type 2 Diabetes Clinical Cohort
discusses	http://id.nlm.nih.gov/mesh/M0006857 http://id.nlm.nih.gov/mesh/M0002696 http://id.nlm.nih.gov/mesh/M0010903 http://id.nlm.nih.gov/mesh/M0013535 http://id.nlm.nih.gov/mesh/M0023752
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008687Q000627 http://id.nlm.nih.gov/mesh/D008687Q000494 http://id.nlm.nih.gov/mesh/D002318Q000517 http://id.nlm.nih.gov/mesh/D002318Q000188 http://id.nlm.nih.gov/mesh/D003924Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000081362 http://id.nlm.nih.gov/mesh/D004364 http://id.nlm.nih.gov/mesh/D015415 http://id.nlm.nih.gov/mesh/D001786Q000378 http://id.nlm.nih.gov/mesh/D000085002 http://id.nlm.nih.gov/mesh/D007004Q000494 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D007004Q000627
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5939 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID264 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4091 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444

Showing number of triples: 1 to 76 of 76.